Posterior Subtenon Triamcinolone Acetonide in Gas-filled Eyes as an Adjunctive Treatment for Complicated Proliferative Diabetic Retinopathy

키워드

참고문헌 (41)

1. Martidis A, "Intravitreal triamcinolone for refractory diabetic macular edema", Ophthalmology, 109, pp.920~927 (2002)
2. Antcliff RJ, "Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study", Ophthalmology, 108, pp.765~772 (2001)
3. Greenberg PB, "Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion", Br J Ophthalmol, 86, pp.247~248 (2002)
4. Danis RP, "Intravitreal triamcinolone acetonide in exudative age-related macular degeneration", Retina, 20, pp.244~250 (2000)
5. Jonas JB, "Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema", Am J Ophthalmol, 132, pp.425~427 (2001)
6. Jonas JB, "Intravitreal triamcinolone acetonide for cataract surgery with iris neovascularization", J Cataract Refract Surg, 28, pp.2040~2041 (2002)
7. Jonas JB, "Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy", Am J Ophthalmol, 131, pp.468~471 (2001)
8. Jonas JB, "Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone", J Glaucoma, 10, pp.284~287 (2001)
9. Rubsamen PE, "Therapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathy", Retina, 17, pp.44~50 (1997)
10. Rubsamen PE, "Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil", Arch Ophthalmol, 112, pp.407~413 (1994)
11. Berger AS, "Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy", Invest Ophthalmol Vis Sci, 37, pp.2318~2325 (1996)
12. Yang CS, "An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy", Arch Ophthalmol, 116, pp.69~77 (1998)
13. Ando N, "Localization and quantitation of blood-retinal barrier breakdown in experimental proliferative vitreoretinopathy", Arch Ophthalmol, 112, pp.117~122 (1994)
14. Faghihi H, "Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial", Retina, 28, pp.1241~1246 (2008)
15. Thompson JT, "Results and prognostic factors in vitrectomy for diabetic vitreous hemorrhage", Arch Ophthalmol, 105, pp.191~195 (1987)
16. Yang CM, "Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy", Ophthalmology, 114, pp.710~715 (2007)
17. Farrahi F, "Sulfur hexafluoride 20% versus lactated ringer’s solution for prevention of early postoperative vitreous hemorrhage after diabetic vitrectomy", J Ophthalmic Vis Res, 5, pp.105~109 (2010)
18. "The classification of retinal detachment with proliferative vitreoretinopathy", Ophthalmology, 90, pp.121~125 (1983)
19. Ahmadieh H, "Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial", Ophthalmology, 115, pp.1938~1943 (2008)
20. Cheema RA, "Triamcinolone acetonide as an adjuvant in the surgical treatment of retinal detachment with proliferative vitreoretinopathy", Ophthalmic Surg Lasers Imaging, 38, pp.365~370 (2007)
21. Munir WM, "Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy", Can J Ophthalmol, 40, pp.598~604 (2005)
22. Verma LK, "A prospective controlled trial to evaluate the adjunctive role of posterior subtenon triamcinolone in the treatment of diffuse diabetic macular edema", J Ocul Pharmacol Ther, 20, pp.277~284 (2004)
23. Helm CJ, "The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis", Am J Ophthalmol, 120, pp.55~64 (1995)
24. Jonas JB, "Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy", Eur J Ophthalmol, 13, pp.468~473 (2003)
25. Sakamoto T, "Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown", Graefes Arch Clin Exp Ophthalmol, 240, pp.423~429 (2002)
26. Jonas JB, "Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases", Prog Retin Eye Res, 24, pp.587~611 (2005)
27. Croasdale CR, "Subconjunctival corticosteroid injections for nonnecrotizing anterior scleritis", Arch Ophthalmol, 117, pp.966~968 (1999)
28. Danis RP, "Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide", Ophthalmology, 103, pp.2099~2104 (1996)
29. Floman N, "Mechanism of steroid action in ocular inflammation: inhibition of prostaglandin production", Invest Ophthalmol Vis Sci, 16, pp.69~73 (1977)
30. Wilson CA, "Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation", Arch Ophthalmol, 110, pp.1155~1159 (1992)
31. Hood PP, "Effect of intravenous corticosteroid on ex vivo leukotriene generation by blood leucocytes of normal and asthmatic patients", Thorax, 54, pp.1075~1082 (1999)
32. Ozaki NK, "Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia", Invest Ophthalmol Vis Sci, 43, pp.1546~1557 (2002)
33. Lafranco Dafflon M, "Posterior sub-Tenon’s steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects", Graefes Arch Clin Exp Ophthalmol, 237, pp.289~295 (1999)
34. Shen L, "Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon application", Ophthalmology, 117, pp.2365~2371 (2010)
35. Entezari M, "Posterior sub-tenon triamcinolone for refractory diabetic macular edema: a randomized clinical trial", Eur J Ophthalmol, 15, pp.746~750 (2005)
36. Smithen LM, "Intravitreal triamcinolone acetonide and intraocular pressure", Am J Ophthalmol, 138, pp.740~743 (2004)
37. Gillies MC, "Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract", Ophthalmology, 112, pp.139~143 (2005)
38. Jonas JB, "Intraocular pressure elevation after intravitreal triamcinolone acetonide injection", Ophthalmology, 112, pp.593~598 (2005)
39. Jonas JB, "Intraocular pressure after intravitreal injection of triamcinolone acetonide", Br J Ophthalmol, 87, pp.24~27 (2003)
40. Gillies MC, "Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial", Arch Ophthalmol, 122, pp.336~340 (2004)
41. Mueller AJ, "The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure", Am J Ophthalmol, 125, pp.158~163 (1998)

관련 논문AI추천